MedPath

Oxygen

Generic Name
Oxygen
Brand Names
Alnox, Ez-OX, Heliox, Oxygen, Southern Medical
Drug Type
Small Molecule
Chemical Formula
O2
CAS Number
7782-44-7
Unique Ingredient Identifier
S88TT14065
Background

Oxygen is an element displayed by the symbol O, and atomic number 8. It is an essential element for human survival. Decreased oxygen levels may be treated with medical oxygen therapy. Treatment with oxygen serves to increase blood oxygen levels and also exerts a secondary effect of decreasing blood flow resistance in the diseased lung, leading to decreased cardiovascular workload in an attempt to oxygenate the lungs. Oxygen therapy is used to treat emphysema, pneumonia, some heart disorders (congestive heart failure), some disorders that cause increased pulmonary artery pressure, and any disease that impairs the body's ability to take up and use gaseous oxygen. Higher level of oxygen than ambient air (hyperoxia) can be introduced under normobaric or hyperbaric conditions.

Indication

Oxygen therapy in clinical settings is used across diverse specialties, including various types of anoxia, hypoxia or dyspnea and any other disease states and conditions that reduce the efficiency of gas exchange and oxygen consumption such as respiratory illnesses, trauma, poisonings and drug overdoses. Oxygen therapy tries to achieve hyperoxia to reduce the extent of hypoxia-induced tissue damage and malfunction.

Associated Conditions
Anemia, Cancer, Hypoxemia, Hypoxia, Migraine, Polycythemia, Pulmonary Hypertension (PH), Respiratory Disorders, Sleep Apnea

Effects of Oxygen Supply After Lung Isolation in Thoracic Surgery

Not Applicable
Completed
Conditions
Thoracic Surgery
One-Lung Ventilation
Mechanical Ventilation
Interventions
First Posted Date
2023-07-14
Last Posted Date
2024-03-12
Lead Sponsor
Medical University Innsbruck
Target Recruit Count
55
Registration Number
NCT05946707
Locations
🇦🇹

Medical University Innsbruck, Innsbruck, Tyrol, Austria

Supplemental Oxygen in Pulmonary Embolism (SO-PE)

Early Phase 1
Recruiting
Conditions
Pulmonary Embolism
Venous Thromboembolism
Metabolomics
Oxygen Inhalation Therapy
Interventions
Device: Non-rebreather mask
First Posted Date
2023-06-07
Last Posted Date
2023-10-19
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
80
Registration Number
NCT05891886
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?

Phase 4
Active, not recruiting
Conditions
Diabetic Foot Ulcer
Amputation
Peripheral Vascular Disease
Interventions
First Posted Date
2023-04-07
Last Posted Date
2024-11-08
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Target Recruit Count
30
Registration Number
NCT05804097
Locations
🇳🇱

Amsterdam UMC, Amsterdam, Noord-Hollad, Netherlands

Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease

Phase 4
Not yet recruiting
Conditions
COPD Exacerbation
COPD Exacerbation Acute
Interventions
First Posted Date
2023-01-30
Last Posted Date
2025-04-23
Lead Sponsor
Central Denmark Region
Target Recruit Count
1888
Registration Number
NCT05703919
Locations
🇩🇰

Prehospital Emergency Medical Servises, Central Denmark Region, Aarhus N, Denmark

Cerebral Nitrosative/Oxidative Stress in Aneurysmal Subarachnoid Haemorrhage

Terminated
Conditions
Subarachnoid Hemorrhage, Aneurysmal
Interventions
First Posted Date
2023-01-17
Last Posted Date
2024-03-19
Lead Sponsor
Rigshospitalet, Denmark
Target Recruit Count
3
Registration Number
NCT05686265
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

Effects of Different Inhalation Oxygen Concentrations on Postoperative Atelectasis

Phase 4
Completed
Conditions
Atelectasis
Interventions
First Posted Date
2022-11-25
Last Posted Date
2024-07-22
Lead Sponsor
China Medical University, China
Target Recruit Count
96
Registration Number
NCT05627024
Locations
🇨🇳

the First Hospital of China Medical University, Shenyang, Liaoning, China

Oxygen Targets in Acute Heart Failure With Pulmonary Congestion

Phase 2
Recruiting
Conditions
Pulmonary Congestion
Acute Heart Failure
Hypoxemia
Interventions
First Posted Date
2022-11-14
Last Posted Date
2025-02-20
Lead Sponsor
Copenhagen University Hospital, Hvidovre
Target Recruit Count
122
Registration Number
NCT05613218
Locations
🇩🇰

Bispebjerg Hospital, Copenhagen, Denmark

🇩🇰

Amager-Hvidovre Hospital, Copenhagen, Denmark

Use of Nitrous Oxide for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Dilatation and Evacuation

Early Phase 1
Not yet recruiting
Conditions
Pain Alleviation
Laminaria Placement
Dilatation and Evacuation
Nitrous Oxide
Interventions
Drug: Nitrous oxide (N2O/O2)
First Posted Date
2022-10-13
Last Posted Date
2022-10-13
Lead Sponsor
Sheba Medical Center
Target Recruit Count
60
Registration Number
NCT05579288
Locations
🇮🇱

Sheba Medical Center, Ramat Gan, Israel

Oxygen Reserve Index and Prevention of Hyperoxemia

Phase 4
Completed
Conditions
Oxygen Reserve Index
Hyperoxia
Hyperoxemia
Fraction of Inspired Oxygen
Interventions
Device: Masimo Root Radical 7
First Posted Date
2022-08-17
Last Posted Date
2023-05-22
Lead Sponsor
Baskent University Ankara Hospital
Target Recruit Count
108
Registration Number
NCT05505032
Locations
🇹🇷

Baskent University Ankara Hospital, Ankara, Cankaya, Turkey

Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys

Phase 3
Recruiting
Conditions
Delayed Graft Function
Ischemia Reperfusion Injury
Kidney Transplant; Complications
Mitochondrial
Interventions
First Posted Date
2022-06-24
Last Posted Date
2024-05-23
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Target Recruit Count
60
Registration Number
NCT05430620
Locations
🇧🇪

Cliniques Universitaires Saint-Luc, Brussel, Woluwé-Saint-Lambert, Belgium

© Copyright 2025. All Rights Reserved by MedPath